FDA orphan drug designation: treatment of uveal melanoma
All entries for: Novelwise Pharmaceuticals Corporation
November 19, 2025
Novelwise Pharmaceuticals Corporation
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of uveal melanoma